|
Market Closed -
Nasdaq
01:30:00 15/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 505.75 USD | -2.07% |
|
+1.95% | +11.56% |
| 12/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 563.12 | +9.04% | 25 | ||||||
| 1,313.08 | +8.61% | 27 | ||||||
| 272.5 | +3.98% | 22 | ||||||
| 276.24 | +10.14% | 29 | ||||||
| 370.31 | +2.21% | 18 | ||||||
| 154.18 | +1.24% | 21 | ||||||
| 211.68 | +33.95% | 22 | ||||||
| 383.66 | -8.18% | 29 | ||||||
| 313.7 | +5.18% | 24 | ||||||
| 157.41 | +13.95% | 27 | ||||||
| 28.61 | +6.74% | 26 | ||||||
| 66.21 | +2.41% | 24 | ||||||
| 94.28 | +23.35% | 23 | ||||||
| 21.61 | +16.42% | 20 | ||||||
| 9,426.67 | +31.38% | 15 | ||||||
| 6,437.69 | +15.81% | 16 | ||||||
| 56.92 | +18.43% | 18 | ||||||
| 79.69 | +48.23% | 16 | ||||||
| 41.4 | +13.36% | 10 | ||||||
| 4.208 | +17.58% | 17 | ||||||
| Average | 1,013.66 | +13.69% | 21 | ||||||
| Weighted average by Cap. | 710.91 | +9.15% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
